Human Metabolome Technologies Expands to U.S., Opening Office in Cambridge, Mass.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Human Metabolome Technologies, Inc. (HMT), the leading developer of capillary electrophoresis mass spectrometry (CE-MS) based metabolomics, today announced the opening of its first U.S. office in Cambridge, Mass. The new office is expected to house up to 20 employees and a laboratory by 2015. HMT is based in Tsuruoka, Japan. “Cambridge provides the perfect combination of academic and industrial arenas, especially associated with the field of life sciences, food engineering and environmental studies,” said Tsutomu (Tom) Hoshiba, President, HMT America. “HMT provides cutting-edge solutions to life scientists, medical doctors and pharmacologists via our state-of-the-art metabolomics technology based on capillary electrophoresis mass spectrometry (CE-MS), and we believe that Cambridge is the place to be for networking with businesses that will make the most of our solutions.”

Back to news